Q4 2023 Holdings
Filed 2024-02-13 | 32 holdings | $427.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology, Inc.(CGEM) | Common | 230031106 | $77.9M | 7,648,268 | 18.2% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $26.7M | 3,289,470 | 6.3% |
| Olema Pharmaceuticals, Inc.(OLMA) | Common | 68062P106 | $26.1M | 1,857,136 | 6.1% |
| Geron Corporation(GERN) | Common | 374163103 | $22.6M | 10,715,620 | 5.3% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $19.1M | 1,745,943 | 4.5% |
| ALX Oncology Holdings Inc.(ALXO) | Common | 00166B105 | $18.8M | 1,264,759 | 4.4% |
| Moonlake Immunotherapeutics(MLTX) | Class A Ord. | 61559X104 | $17.8M | 294,576 | 4.2% |
| Crinetics Pharmaceuticals Inc.(CRNX) | Common | 22663K107 | $17.0M | 478,234 | 4.0% |
| Karuna Therapeutics Inc | Common | 48576A100 | $16.9M | 53,279 | 3.9% |
| Insmed Incorporated(INSM) | Common | 457669307 | $16.4M | 528,150 | 3.8% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $14.4M | 611,181 | 3.4% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $12.0M | 1,639,849 | 2.8% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $11.7M | 382,598 | 2.7% |
| Amicus Therapeutics Inc.(FOLD) | Common | 03152W109 | $10.2M | 715,883 | 2.4% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $9.9M | 549,078 | 2.3% |
| Madrigal Pharmaceuticals inc(MDGL) | Common | 558868105 | $9.5M | 40,910 | 2.2% |
| Structure Therapeutics Inc.(GPCR) | Sponsored ADS | 86366E106 | $9.4M | 230,696 | 2.2% |
| Avadel Pharmaceuticals PLC | Sponsored ADR | 05337M104 | $9.4M | 664,986 | 2.2% |
| Morphic Holding Inc | Common | 61775R105 | $9.3M | 323,742 | 2.2% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $9.2M | 2,388,011 | 2.2% |
| Relay Therapeutics Inc.(RLAY) | Common | 75943R102 | $9.2M | 832,017 | 2.1% |
| Xeris Biopharma Holdings Inc(XERS) | Common | 98422E103 | $9.0M | 3,847,232 | 2.1% |
| Verve Therapeutics, Inc | Common | 92539P101 | $8.9M | 638,163 | 2.1% |
| Revolution Medicines, Inc.(RVMD) | Common | 76155X100 | $7.8M | 273,408 | 1.8% |
| Axsome Therapeutics, Inc.(AXSM) | Common | 05464T104 | $7.4M | 93,387 | 1.7% |
| Viking Therapeutics Inc(VKTX) | Common | 92686J106 | $6.1M | 325,284 | 1.4% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $4.0M | 5,095,912 | 0.9% |
| Harpoon Therapeutics, Inc. | Common | 41358P205 | $3.6M | 319,670 | 0.9% |
| Disc Medicine Inc(IRON) | Common | 254604101 | $2.9M | 50,000 | 0.7% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $2.2M | 100,000 | 0.5% |
| Inozyme Pharma Inc. | Common | 45790W108 | $1.4M | 323,813 | 0.3% |
| Phathom Pharmaceuticals inc(PHAT) | Common | 71722W107 | $639.1K | 70,000 | 0.1% |